Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Jane Thomassen

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Nature|October 3, 2014
Lung disease: Treatment by cell transplantMary Jane Thomassen, Mani S Kavuru
International Journal of Molecular Sciences|April 30, 2021
Studies in a Murine Granuloma Model of Instilled Carbon Nanotubes: Relevance to SarcoidosisBarbara P Barna, Anagha Malur, Mary Jane Thomassen
Treatments in Respiratory Medicine|September 8, 2004
Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategiesSaiprakash B Venkateshiah, Mary Jane Thomassen, Mani S Kavuru
Cleveland Clinic Journal of Medicine|February 26, 2004
Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversiesDaniel A Culver, Mary Jane Thomassen, Mani S Kavuru
Clinical Immunology (Orlando, Fla.)|December 25, 2002
Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosisTracey L Bonfield, Mani S Kavuru, Mary Jane Thomassen
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Pulmonary Alveolar Proteinosis: recent advancesPeter J Mazzone, Mary Jane Thomassen, Mani S Kavuru
Frontiers in Immunology|February 15, 2021
Editorial: Novel Insights Into the Immunology of Pulmonary Granulomatous DiseasesMary Jane Thomassen, Marc A Judson, Barbara P Barna
Nanomaterials (Basel, Switzerland)|December 20, 2014
Carbon Nanotubes and Chronic Granulomatous DiseaseBarbara P Barna, Marc A Judson, Mary Jane Thomassen
Advances in Experimental Medicine and Biology|May 21, 2021
Inflammatory Pathways in SarcoidosisBarbara P Barna, Marc A Judson, Mary Jane Thomassen
The Journal of Applied Laboratory Medicine|May 24, 2020
Utilization of LC-MS to Determine Monoclonal Gammopathy-Associated Granulocyte Macrophage Colony Stimulating Factor Antibody and Novel Treatment of Pulmonary Alveolar ProteinosisSelin Ekici, Anagha Malur, Mary Jane Thomassen, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Nature|October 3, 2014
Lung disease: Treatment by cell transplantMary Jane Thomassen, Mani S Kavuru
International Journal of Molecular Sciences|April 30, 2021
Studies in a Murine Granuloma Model of Instilled Carbon Nanotubes: Relevance to SarcoidosisBarbara P Barna, Anagha Malur, Mary Jane Thomassen
Treatments in Respiratory Medicine|September 8, 2004
Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategiesSaiprakash B Venkateshiah, Mary Jane Thomassen, Mani S Kavuru
Cleveland Clinic Journal of Medicine|February 26, 2004
Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversiesDaniel A Culver, Mary Jane Thomassen, Mani S Kavuru
Clinical Immunology (Orlando, Fla.)|December 25, 2002
Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosisTracey L Bonfield, Mani S Kavuru, Mary Jane Thomassen
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Pulmonary Alveolar Proteinosis: recent advancesPeter J Mazzone, Mary Jane Thomassen, Mani S Kavuru
Frontiers in Immunology|February 15, 2021
Editorial: Novel Insights Into the Immunology of Pulmonary Granulomatous DiseasesMary Jane Thomassen, Marc A Judson, Barbara P Barna
Nanomaterials (Basel, Switzerland)|December 20, 2014
Carbon Nanotubes and Chronic Granulomatous DiseaseBarbara P Barna, Marc A Judson, Mary Jane Thomassen
Advances in Experimental Medicine and Biology|May 21, 2021
Inflammatory Pathways in SarcoidosisBarbara P Barna, Marc A Judson, Mary Jane Thomassen
The Journal of Applied Laboratory Medicine|May 24, 2020
Utilization of LC-MS to Determine Monoclonal Gammopathy-Associated Granulocyte Macrophage Colony Stimulating Factor Antibody and Novel Treatment of Pulmonary Alveolar ProteinosisSelin Ekici, Anagha Malur, Mary Jane Thomassen, et al.
Pageof 7